428 related articles for article (PubMed ID: 29449433)
1. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
[TBL] [Abstract][Full Text] [Related]
2. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
[TBL] [Abstract][Full Text] [Related]
3. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.
Criado I; Rodríguez-Caballero A; Gutiérrez ML; Pedreira CE; Alcoceba M; Nieto W; Teodosio C; Bárcena P; Romero A; Fernández-Navarro P; González M; Almeida J; Orfao A;
Haematologica; 2018 Jul; 103(7):1198-1208. PubMed ID: 29567775
[TBL] [Abstract][Full Text] [Related]
4. Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.
Villegas Gracia R; Franco Alzate C; Rendón Henao J; Torres Hernández JD; Jaramillo Arbelaez PE
Colomb Med (Cali); 2016 Jun; 47(2):81-6. PubMed ID: 27546929
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
Ojha J; Secreto C; Rabe K; Ayres-Silva J; Tschumper R; Dyke DV; Slager S; Fonseca R; Shanafelt T; Kay N; Braggio E
Leukemia; 2014 Dec; 28(12):2395-8. PubMed ID: 25034147
[No Abstract] [Full Text] [Related]
6. Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Winkelmann N; Rose-Zerilli M; Forster J; Parry M; Parker A; Gardiner A; Davies Z; Steele AJ; Parker H; Cross NC; Oscier DG; Strefford JC
Haematologica; 2015 Jun; 100(6):e237-9. PubMed ID: 25710457
[No Abstract] [Full Text] [Related]
7. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
8. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
[TBL] [Abstract][Full Text] [Related]
9. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.
Furtado FM; Scheucher PS; Santana BA; Scatena NF; Calado RT; Rego EM; Matos DM; Falcão RP
Braz J Med Biol Res; 2017 Apr; 50(5):e6019. PubMed ID: 28423121
[TBL] [Abstract][Full Text] [Related]
10. BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL).
Nasr AA; Fund X; Barreau S; Desterke C; Borie C; Oudrhiri N; Faivre J; Bennaceur-Griscelli A; Turhan AG
Leuk Lymphoma; 2024 May; 65(5):692-695. PubMed ID: 38293748
[No Abstract] [Full Text] [Related]
11. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
Karube K; Scarfò L; Campo E; Ghia P
Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders.
Henriques A; Rodríguez-Caballero A; Criado I; Langerak AW; Nieto WG; Lécrevisse Q; González M; Cortesão E; Paiva A; Almeida J; Orfao A
Haematologica; 2014 May; 99(5):897-907. PubMed ID: 24488564
[TBL] [Abstract][Full Text] [Related]
14. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia.
Marti GE; Carter P; Abbasi F; Washington GC; Jain N; Zenger VE; Ishibe N; Goldin L; Fontaine L; Weissman N; Sgambati M; Fauget G; Bertin P; Vogt RF; Slade B; Noguchi PD; Stetler-Stevenson MA; Caporaso N
Cytometry B Clin Cytom; 2003 Mar; 52(1):1-12. PubMed ID: 12599176
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.
Amato D; Oscier DG; Davis Z; Mould S; Zheng J; Kolomietz E; Wang C
Am J Clin Pathol; 2007 Aug; 128(2):333-8. PubMed ID: 17638670
[TBL] [Abstract][Full Text] [Related]
16. Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia.
Quinten E; Sepúlveda-Yáñez JH; Koning MT; Eken JA; Pfeifer D; Nteleah V; De Groen RAL; Saravia DA; Knijnenburg J; Stuivenberg-Bleijswijk HE; Pantic M; Agathangelidis A; Keppler-Hafkemeyer A; Van Bergen CAM; Uribe-Paredes R; Stamatopoulos K; Vermaat JSP; Zirlik K; Navarrete MA; Jumaa H; Veelken H
Haematologica; 2024 Mar; 109(3):824-834. PubMed ID: 37439337
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of monoclonal B-cell lymphocytosis.
Mowery YM; Lanasa MC
Cancer Control; 2012 Jan; 19(1):8-17. PubMed ID: 22143058
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
[TBL] [Abstract][Full Text] [Related]
19. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
Scarfò L; Ghia P
Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
